Adaptimmune Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details
Uncategorized
- Pay vs Performance Disclosure
- Insider Trading Arrangements

Restructuring (Tables)

v3.24.0.1

Restructuring (Tables)

12 Months Ended

Dec. 31, 2023

Restructuring

Schedule of amounts incurred in relation to the redundancy programme


			One-time
	Contractual		employee		Total
	termination		termination		restructuring
	benefits		benefits		costs
Cumulative amount incurred to December 31, 2022	$	1,171	$	1,114	$	2,285
Amount incurred in the year ended December 31, 2023		778		925		1,703
Total amount and cumulative amount incurred to December 31, 2023	$	1,949	$	2,039	$	3,988

Schedule of changes in the restructuring provision


			One-time
	Contractual		employee		Total
	termination		termination		restructuring
	benefits		benefits		provision
Provision at January 1, 2022	$	—	$	—	$	—
Costs incurred and charged to General and administrative expenses		1,171		1,114		2,285
Provision at December 31, 2022	$	1,171	$	1,114	$	2,285

Costs incurred and charged to General and administrative expenses		670		947		1,617
Costs paid during the period		(1,955)		(2,041)		(3,996)
Adjustments to the liability		108		(22)		86
Effect of foreign exchange rates		6		2		8
Provision at December 31, 2023	$	—	$	—	$	—

Schedule of amounts incurred in relation to redundancies


	Year ended
	December 31, 2023
Severance and other cash payments	$	5,655
Accelerated vesting of share-based compensation awards		1,032
Total and cumulative amount incurred to December 31, 2023	$	6,687

Summary of changes in the liability in the Consolidated Balance Sheet


	Liability
Liability at June 1, 2023	$	805
Costs incurred and charged to Research and development expenses		1,267
Costs incurred and charged to General and administrative expenses		4,388
Costs paid during the period		(5,887)
Liability at December 31, 2023	$	573

- Definition

Tabular disclosure of expected costs to be incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.

+ References

No definition available.

+ Details

Name:	adap_RestructuringAndRelatedCostsExpectToBeIncurredTableTextBlock
Namespace Prefix:	adap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of changes in the liability in the Consolidated Balance Sheet.

+ References

No definition available.

+ Details

Name:	adap_ScheduleOfChangesInLiabilityInConsolidatedBalanceSheet
Namespace Prefix:	adap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 5.P.3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482017/420-10-50-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.P.4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2

+ Details

Name:	us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482017/420-10-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2

+ Details

Name:	us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration